U.S. flag

An official website of the United States government

NM_000516.7(GNAS):c.565_568del (p.Asp189fs) AND Progressive osseous heteroplasia

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jul 15, 2008
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000017301.40

Allele description [Variation Report for NM_000516.7(GNAS):c.565_568del (p.Asp189fs)]

NM_000516.7(GNAS):c.565_568del (p.Asp189fs)

Gene:
GNAS:GNAS complex locus [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
20q13.32
Genomic location:
Preferred name:
NM_000516.7(GNAS):c.565_568del (p.Asp189fs)
Other names:
D189MfsX14
HGVS:
  • NC_000020.11:g.58909196_58909199del
  • NG_016194.2:g.74457_74460del
  • NM_000516.7:c.565_568delMANE SELECT
  • NM_001077488.5:c.568_571del
  • NM_001077489.4:c.520_523del
  • NM_001077490.3:c.*426_*429del
  • NM_001309840.2:c.388_391del
  • NM_001309861.2:c.388_391del
  • NM_016592.5:c.*471_*474del
  • NM_080425.4:c.2494_2497del
  • NM_080426.4:c.523_526del
  • NP_000507.1:p.Asp189fs
  • NP_001070956.1:p.Asp190fs
  • NP_001070957.1:p.Asp174fs
  • NP_001296769.1:p.Asp130fs
  • NP_001296790.1:p.Asp130fs
  • NP_536350.2:p.Asp832fs
  • NP_536351.1:p.Asp175fs
  • NC_000020.10:g.57484249_57484252del
  • NC_000020.10:g.57484251_57484254del
  • NM_000516.4:c.565_568del
  • NM_000516.4:c.565_568delGACT
  • NM_000516.5:c.565_568delGACT
  • NM_000516.7:c.563_566delMANE SELECT
  • NM_001077489.4:c.520_523del
  • NM_080425.2:c.2494_2497delGACT
  • NP_000507.1:p.Asp189MetfsTer14
  • NP_000507.1:p.Asp189MetfsTer14
Note:
NCBI staff reviewed the sequence information reported in PubMed 1505964 Fig. 2 to determine the location of this allele on the current reference sequence.
Protein change:
D130fs
Links:
OMIM: 139320.0011; dbSNP: rs587776829
NCBI 1000 Genomes Browser:
rs587776829
Molecular consequence:
  • NM_001077490.3:c.*426_*429del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_016592.5:c.*471_*474del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_000516.7:c.565_568del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001077488.5:c.568_571del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001077489.4:c.520_523del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001309840.2:c.388_391del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001309861.2:c.388_391del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_080425.4:c.2494_2497del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_080426.4:c.523_526del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Progressive osseous heteroplasia (POH)
Synonyms:
ECTOPIC OSSIFICATION, FAMILIAL; Osseus Heteroplasia, Progressive
Identifiers:
MONDO: MONDO:0008153; MedGen: C0334041; Orphanet: 2762; OMIM: 166350; Human Phenotype Ontology: HP:0025027

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000037573OMIM
no assertion criteria provided
Pathogenic
(Jul 15, 2008)
germlineliterature only

PubMed (6)
[See all records that cite these PMIDs]

Shore, E. M., Kaplan, F. S., Levine, M. A. GNAS1 mutations and progressive osseous heteroplasia. (Letter) New Eng. J. Med. 346: 1670-1671, 2002.,

SCV000611857GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedliterature only
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A heterozygous 4-bp deletion mutation in the Gs alpha gene (GNAS1) in a patient with Albright hereditary osteodystrophy.

Weinstein LS, Gejman PV, de Mazancourt P, American N, Spiegel AM.

Genomics. 1992 Aug;13(4):1319-21.

PubMed [citation]
PMID:
1505964

GNAS1 mutations and progressive osseous heteroplasia.

Ahmed SF, Barr DG, Bonthron DT.

N Engl J Med. 2002 May 23;346(21):1669-71. No abstract available.

PubMed [citation]
PMID:
12024004
See all PubMed Citations (9)

Details of each submission

From OMIM, SCV000037573.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (6)

Description

In a patient with PHP1A (103580), Weinstein et al. (1992) identified a heterozygous 4-bp deletion (565delCTGA) in exon 7 of the GNAS1 gene, resulting in a frameshift and premature stop codon. Analysis of lymphocyte RNA by reverse transcription-PCR and direct sequencing showed that the GNAS1 allele bearing the mutation was not expressed as mRNA. Consistent with this, Northern blot analysis revealed an approximately 50% deficiency in steady-state levels of GNAS1 mRNA.

Ahmed et al. (1998) identified this deletion mutation in 2 unrelated families with PHP Ia.

Shore et al. (2002) provided direct evidence that the 4-bp deletion can cause either progressive osseous heteroplasia (POH; 166350) or Albright hereditary osteodystrophy without hormone resistance (PPHP; 612463) in the same family. Five sisters with POH had inherited this mutation from the father in whom the mutation was nonpenetrant. Three offspring of these sisters had AHO, including traces of subcutaneous ossification. Shore et al. (2002) suggested that POH requires paternal inheritance of a GNAS1 mutation, whereas hormone resistance is more likely to occur when the genetic defect is maternally inherited.

Ahmed et al. (2002) cautioned against a premature conclusion that POH may require paternal inheritance. In a family reported by Ahmed et al. (1998), the 4-bp deletion was found in a brother and sister and in their mother but not in their father. Aside from brachymetacarpia and short stature, the mother did not have features of AHO. The daughter had typical features of AHO and hormone resistant PHP1A; in contrast, her brother presented in the first year of life with ossification of subcutaneous tissue that was followed by progressive, generalized heterotopic ossification of skeletal muscle, without any clear evidence of hormone resistance. These cases exemplified the wide phenotypic heterogeneity in persons with mutations in GNAS1, even within 1 family.

Bastepe and Juppner (2002) suggested that, like some patients who have either PHP type Ia or PHP type Ib, the son described by Ahmed et al. (1998) may have developed resistance to parathyroid hormone later in life or not at all. Given that the patient's sister and mother had PHP type Ia and PPHP, respectively, POH resulting from maternally inherited GNAS1 mutations may actually represent an incomplete form of PHP type Ia. Bastepe and Juppner (2002) suggested that the underlying mechanism for this form of POH may be distinct from that described by Shore et al. (2002), which appears to result only from paternally inherited GNAS1 mutations.

Adegbite et al. (2008) identified heterozygosity for the 565delCTGA mutation in the GNAS gene in 13 POH cases (10 familial cases among 3 different families, and 3 individual spontaneous cases). The mutation resulted in variable severity and pleiotropy, both in family members and in unrelated sporadic cases.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000611857.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 2, 2024